Results 61 to 70 of about 46,173 (165)

Uneven Global Distribution of Theranostics. [PDF]

World J Nucl Med
Kairemo K, Al-Ibraheem A.
europepmc   +1 more source

Availability, accessibility, and economic feasibility of radionuclide therapies in Africa: a systematic review and quantitative infrastructure analysis. [PDF]

Front Nucl Med
Ibrahim EA.
europepmc   +1 more source

RADIONUCLIDES IN UROLOGY

The Japanese Journal of Urology, 1994
openaire   +3 more sources

Emergency Appendectomy during the Early Phase after ¹⁷⁷Lu-DOTATATE Therapy: A Case Report with Perioperative Radiation Safety after PRRT. [PDF]

Surg Case Rep
Nakagawa K, Fukata T, Sakurai H, Yambe K, Kondo N, Takami K, Yamamoto K, Katayose Y.   +7 more
europepmc   +1 more source

Radionuclide theranostics: advances and clinical applications in lung cancer. [PDF]

Front Oncol
Yang Y, Fu J, Tang S, Liu T, Hu H, Guo H, Wen L, Yang Y, Liu C, Zhang Y, Yu L, Zhou H.   +11 more
europepmc   +1 more source

Theranostics and molecular imaging are taking off: current situation, requirements and how to train more physicians to fill the gap. A perspective from three different continents. [PDF]

Br J Radiol
Veit-Haibach P, Lam W, Wong RKS, Cook GJR.   +3 more
europepmc   +1 more source

The Role of Phytoplankton and Sediment Microbial Community on Sr, U, Pu, and Am Behavior in Freshwater Lake Dryazlo. [PDF]

Biology (Basel)
Popova M, Riabov V, Popova N, Artemiev G, Safonov A.   +4 more
europepmc   +1 more source

Combined SSTR2-targeted Analogue with ¹⁷⁷Lu-DOTATATE radionuclide and octreotide therapy for refractory meningioma: a case report. [PDF]

Front Oncol
Yuen CA, Jafarvand M, Kamson DO, Chu E, Soun JE, Yong WH, Hsu FP, Bow H, Zheng M, Srinivas SM.   +9 more
europepmc   +1 more source

The gastrin-releasing peptide receptor in oncology: a comprehensive review of recent advances in targeted radionuclide theranostics. [PDF]

Front Oncol
Yang Y, Fu J, Tang S, Liu T, Hu H, Guo H, Wen L, Yang Y, Liu C, Yi G, Yu L, Zhou H.   +11 more
europepmc   +1 more source

Immunohistochemical Evaluation of Integrin β6 Expression in Triple-Negative Breast Cancer as a Predictive Biomarker for Therapeutic and Diagnostic Radionuclides. [PDF]

Biomolecules
Tuffaha M, Hananeh W, Bangemann N, Tuffaha A, Starke M.   +4 more
europepmc   +1 more source